NEDD4L and Sezary syndrome: Despite its low expression in most tumors, NEDD4L is highly expressed in a few, such as Sézary syndrome (Booken et al., 2008), melanoma (Kito et al., 2014), and invasive gallbladder cancer (Takeuchi et al., 2011).